PATENT CLAIM ANALYSIS

Application Number: 15761623
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-12
Patent Classification: ["514", "561000"]

Abstract:
The present invention relates to a pharmaceutical topical gel solution that contains 5-aminolevulinic acid (5-ALA) and an aqueous low viscous gel matrix. This invention also relates to a pharmaceutical preparation containing this composition. The formulation of this type can be used in photodynamic therapy as well as in the photodynamic detection of abnormally proliferating cells.

Claim (Index 7):
The composition of  claim 1 , wherein the one or more glycosaminoglycan compounds are selected from chondroitin sulfate, keratan sulfate, dermatan sulfate, heparin sulfate, heparan sulfate and/or hyaluronic acid/sodium hyaluronate (non-sulfated glycosaminoglycan).

Metadata:
- Claim Count in Document: 29.0
- Percentile: 90.0
- Lexical Diversity: 1.30435
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12735214', '14707639', '13098844', '16071485', '13673704']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7320351897669292
- 35 USC 102 Novelty (BERT): 0.5017644819967694
- Combined Prediction Score: 0.7090081189899132
- Mean Citation Score: 204.407064
- Max Citation Score: 215.96848
- Similarity Product: 152.7133276441383

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test